Mapping the vitiligo patient journey: from awareness to treatment or coping strategies.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

4 citing papers in PubMed.

1. Post Hoc Subgroup and Body Region Analyses of VASI Outcomes Among Patients with Vitiligo in a Phase 2 Povorcitinib Trial.Advances in therapy · 2026
   Trial
2. Understanding vitiligo through the eyes of a typical patient in the U.S.Frontiers in medicine · 2025
   Article
3. Comprehensive analysis of life quality of patients with vitiligo in Romania: insights from a multivariate approach.Frontiers in medicine · 2025
   Article
4. Evaluating the usefulness of ChatGPT and Gemini in generating educational content for patients with vitiligo: a comparative cross-sectional study.Proceedings (Baylor University. Medical Center)
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as